These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 9925787

  • 1. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E, St Charles R, Tulinsky A.
    J Mol Biol; 1999 Feb 05; 285(5):2089-104. PubMed ID: 9925787
    [Abstract] [Full Text] [Related]

  • 2. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 3. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A, Ruf W, Rao LV.
    Thromb Haemost; 2001 Mar 15; 85(3):458-63. PubMed ID: 11307815
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G, Johnson DJ, Tuddenham EG, Harlos K.
    J Struct Biol; 1999 Oct 15; 127(3):213-23. PubMed ID: 10544046
    [Abstract] [Full Text] [Related]

  • 5. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP.
    Thromb Haemost; 2001 Oct 15; 86(4):959-72. PubMed ID: 11686353
    [Abstract] [Full Text] [Related]

  • 6. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
    Banner DW, D'Arcy A, Chène C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D.
    Nature; 1996 Mar 07; 380(6569):41-6. PubMed ID: 8598903
    [Abstract] [Full Text] [Related]

  • 7. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J, Perera L, Stafford D, Pedersen L.
    J Mol Biol; 2001 Apr 13; 307(5):1503-17. PubMed ID: 11292356
    [Abstract] [Full Text] [Related]

  • 8. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K, Persson E, Carlsson U, Svensson M.
    Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1111-6. PubMed ID: 16970919
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
    Johnson K, Zaror I, Bauer D, Choi Y, Creasey A, Innis M.
    Thromb Haemost; 1998 Oct 27; 80(4):585-7. PubMed ID: 9798974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ, Rusinova E, Gentry RD, Andree H, Nemerson Y.
    Biochemistry; 2005 Jun 07; 44(22):8187-97. PubMed ID: 15924438
    [Abstract] [Full Text] [Related]

  • 14. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ, Case BL, Dice TA, Fenton RL, Hayes MJ, Jones DE, Neumann WL, Wood RS, Lachance RM, Girard TJ, Nicholson NS, Clare M, Stegeman RA, Stevens AM, Stallings WC, Kurumbail RG, South MS.
    J Med Chem; 2003 Sep 11; 46(19):4050-62. PubMed ID: 12954058
    [Abstract] [Full Text] [Related]

  • 15. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 16. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
    Jin J, Chang J, Chang JY, Kelley RF, Stafford DW, Straight DL.
    Biochemistry; 1999 Jan 26; 38(4):1185-92. PubMed ID: 9930978
    [Abstract] [Full Text] [Related]

  • 17. The lipoprotein-associated coagulation inhibitor.
    Broze GJ, Girard TJ, Novotny WF.
    Prog Hemost Thromb; 1991 Jan 26; 10():243-68. PubMed ID: 2008533
    [Abstract] [Full Text] [Related]

  • 18. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E, Olsen OH.
    FEBS J; 2009 Jun 26; 276(11):3099-109. PubMed ID: 19490111
    [Abstract] [Full Text] [Related]

  • 19. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties.
    Stassen JM, Lambeir AM, Matthyssens G, Ripka WC, Nyström A, Sixma JJ, Vermylen J.
    Thromb Haemost; 1995 Aug 26; 74(2):646-54. PubMed ID: 8585001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.